Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-04-16 @ 1:12 PM
Study NCT ID:
NCT00804193
Status:
COMPLETED
Last Update Posted:
2021-10-27
First Post:
2008-12-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Phases
| Phase Brief | Phase Text | View |
|---|---|---|
| None | NA | View |
Observational Models:
Time Perspective List:
Who Masked List: